Podcast on the new drugs coming to the market

I’m staying hopeful that these meds can improve our lives.

2 Likes

It’s stuff you can hear anywhere. No one’s talking about patient expierences or more in depth conversations about…really anything! It’s actually starting to get really frustrating as I can imagine we are all bursting with questions.

1 Like

I’m sorry I commented on that prematurely. It was actually a worthwhile listen. There are a vast amount of people who suffer with just negative symtoms and residual schizophrenia and just anhedonia apathy and avolition (inability to work) the more I read about these meds the more I realize they are for acute schizophrenia it seems and not anything having to do with tackling negative symptoms in purely anhedonic people and it’s alllllll so frustrating….
I just. Don’t. Know

1 Like

I’m a lot more optimistic for the young people with this illness Because I believe that many of the new drugs will show up to be a lot less harmful than the old drugs. And even if they do not directly improve cognitive-negative symptoms then they won’t worsen them likewise the all the drugs used today that all in more or less degree affect the dopamine 2 receptors which worsen those symptoms unlike the new meds that works for positives without affecting D2.

1 Like